What does Dilopsy do?

Dilopsy is a healthcare practice in Oostende. Private Limited, started on 2 April 2008, 3 establishments.

What is the address of Dilopsy?

The registered office of Dilopsy is located at Oude Molenstraat 28, 8400 Oostende.

Is Dilopsy still active?

Yes. According to the CBE (29 October 2026) Dilopsy is active, legal situation “Normale toestand”, started on 2 April 2008.

Is Dilopsy registered on Peppol?

Yes, Dilopsy is registered on the Peppol network with ID 0208:0896899711.

What is the enterprise number of Dilopsy?

The enterprise number of Dilopsy is BE0896899711.

When was Dilopsy founded?

Dilopsy was founded on 2 April 2008.

Who are the directors of Dilopsy?

According to the 2024 annual accounts, the directors of Dilopsy are: Audrey Huyvaert.

Is Dilopsy a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2008; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 3 establishments in the CBE.

How much profit did Dilopsy make in 2024?

Dilopsy posted a profit after taxes of € 10,484 in financial year 2024.

What is the revenue of Dilopsy?

As a small company, Dilopsy is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 21,521.

Dilopsy (Private Limited) - Oostende - BE0896899711

Dossier Dilopsy, printed on 29 October 2026 from databakkes.be/en/0896899711/dilopsy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dilopsy from Oostende, company number BE0896899711, closed financial year 2024 with a result of € 10,484 after tax. For that financial year Dilopsy recorded a gross margin of € 21,521 and equity of € 45,836. Compared with financial year 2023, the result moved from € -5,004 to € 10,484. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 25, 2025.

What it is worth Growing

€ 45,836

▲ 30% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 10,484

▲ still € 5,004 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 21,685

▼ 7% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 27,236.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,751

▼ 39% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 14,770

€ 2,811 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 8,595

▼ 31% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,325

▲ 150% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 17,061 Gross margin 2021: € 17,061 First fiscal year in the series	€ 7,951 Gross margin 2022: € 7,951 ▼ 53% vs 2021 (€ 17,061) Unfavourable step	€ -343 Gross margin 2023: € -343 ▼ € 8,295 vs 2022 (€ 7,951) Unfavourable step	€ 21,521 Gross margin 2024: € 21,521 ▲ € 21,864 vs 2023 (€ -343) Favourable step	▲ € 21,864
Profit after taxes	€ 9,827 Profit after taxes 2021: € 9,827 First fiscal year in the series	€ 2,226 Profit after taxes 2022: € 2,226 ▼ 77% vs 2021 (€ 9,827) Unfavourable step	€ -5,004 Profit after taxes 2023: € -5,004 ▼ € 7,230 vs 2022 (€ 2,226) Unfavourable step	€ 10,484 Profit after taxes 2024: € 10,484 ▲ € 15,488 vs 2023 (€ -5,004) Favourable step	▲ € 15,488
Equity	€ 38,130 Equity 2021: € 38,130 First fiscal year in the series	€ 40,356 Equity 2022: € 40,356 ▲ 6% vs 2021 (€ 38,130) Favourable step	€ 35,352 Equity 2023: € 35,352 ▼ 12% vs 2022 (€ 40,356) Unfavourable step	€ 45,836 Equity 2024: € 45,836 ▲ 30% vs 2023 (€ 35,352) Favourable step	▲ 30%
Total debts	€ 13,383 Total debts 2021: € 13,383 First fiscal year in the series	€ 9,959 Total debts 2022: € 9,959 ▼ 26% vs 2021 (€ 13,383) Favourable step	€ 14,564 Total debts 2023: € 14,564 ▲ 46% vs 2022 (€ 9,959) Unfavourable step	€ 27,839 Total debts 2024: € 27,839 ▲ 91% vs 2023 (€ 14,564) Unfavourable step	▲ 91%
Cash	€ 29,409 Cash 2021: € 29,409 First fiscal year in the series	€ 25,267 Cash 2022: € 25,267 ▼ 14% vs 2021 (€ 29,409) Unfavourable step	€ 23,352 Cash 2023: € 23,352 ▼ 8% vs 2022 (€ 25,267) Unfavourable step	€ 21,685 Cash 2024: € 21,685 ▼ 7% vs 2023 (€ 23,352) Unfavourable step	▼ 7%
Retained profit	€ 19,530 Retained profit 2021: € 19,530 First fiscal year in the series	€ 21,756 Retained profit 2022: € 21,756 ▲ 11% vs 2021 (€ 19,530) Favourable step	€ 16,752 Retained profit 2023: € 16,752 ▼ 23% vs 2022 (€ 21,756) Unfavourable step	€ 27,236 Retained profit 2024: € 27,236 ▲ 63% vs 2023 (€ 16,752) Favourable step	▲ 63%
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 14,770 Bank debt 2024: € 14,770 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 51,513 Balance sheet total 2021: € 51,513 First fiscal year in the series	€ 50,316 Balance sheet total 2022: € 50,316 ▼ 2% vs 2021 (€ 51,513) Unchanged	€ 49,916 Balance sheet total 2023: € 49,916 ▼ 1% vs 2022 (€ 50,316) Unchanged	€ 73,675 Balance sheet total 2024: € 73,675 ▲ 48% vs 2023 (€ 49,916) Unchanged	▲ 48%

Key figures of Dilopsy, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dilopsy?

What happened at Dilopsy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 25, 2025 New annual accounts for financial year 2024: profit of € 10,484. Source: NBB ↗
Nov 1, 2021 New establishment in Brugge. KBO
Sep 1, 2010 New establishment in Oostende. KBO
Jan 1, 2009 New establishment in Gent. KBO
Apr 2, 2008 Start of the company according to the CBE. KBO
2008 Audrey Huyvaert became a director. NBB

In short

From € 9,827 profit in 2021 to € 10,484 profit in 2024.

Paid € 10,765 in corporate taxes since 2021.

Best year ever: 2024, with € 10,484 profit.

Original PDFs at the National Bank ↗

Management

Audrey Huyvaert

Dilopsy

HOMIBEL

Behind Dilopsy is Audrey Huyvaert. Audrey Huyvaert is also behind HOMIBEL.

Directors

According to the 2024 annual accounts

Audrey Huyvaert

Director

Also active at: HOMIBEL

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Oude Molenstraat 28

8400 Oostende

2.191.493.680

Vlaanderenstraat 117 box 102

9000 Gent

Active since 1 January 2009

2.323.180.682

Fosterpark 2 box 0.01

8000 Brugge

Active since 1 November 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0896.899.711

VAT number

BE 0896.899.711

Registered office

Oude Molenstraat 28, 8400 Oostende

Names & denominations

Dilopsy

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 April 2008

Peppol

Active · Active since 24 Jul 2026

Activities · NACE

Activiteiten op het gebied van psychologie

Activiteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen

Activiteiten op het gebied van voeding

Activiteiten van risicoanalisten en schadetaxateurs

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Dilopsy

Financials

What happened to Dilopsy?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions